Prostatic Artery Embolization as an Alternative to Indwelling Bladder Catheterization to Manage Benign Prostatic Hyperplasia in Poor Surgical Candidates
- 27 January 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in CardioVascular and Interventional Radiology
- Vol. 40 (4), 530-536
- https://doi.org/10.1007/s00270-017-1582-8
Abstract
To prospectively assess discontinuation of indwelling bladder catheterization (IBC) and relief of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) following prostate artery embolization (PAE) in poor surgical candidates. Patients ineligible for surgical intervention were offered PAE after at least 1 month of IBC for management of urinary retention secondary to BPH; exclusion criteria for PAE included eligibility for surgery, active bladder cancer or known prostate cancer. Embolization technical and clinical success were defined as bilateral prostate embolization and removal of IBC, respectively. Patients were followed for at least 6 months and evaluated for International Prostate Symptom Score, quality of life, prostate size and uroflowmetric parameters. A total of 43 patients were enrolled; bilateral embolization was performed in 33 (76.7%), unilateral embolization was performed in 8 (18.6%), and two patients could not be embolized due to tortuous and atherosclerotic pelvic vasculature (4.7%). Among the patients who were embolized, mean prostate size decreased from 75.6 ± 33.2 to 63.0 ± 23.2 g (sign rank p = 0.0001, mean reduction of 19.6 ± 17.3%), and IBC removal was achieved in 33 patients (80.5%). Clavien II complications were reported in nine patients (21.9%) and included urinary tract infection (three patients, 7.3%) and recurrent acute urinary retention (six patients, 14.6%). Nine patients (22.0%) experienced post-embolization syndrome. PAE is a safe and feasible for the relief of LUTS and IBC in highly comorbid patients without surgical treatment options.Keywords
This publication has 26 references indexed in Scilit:
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2013
- Prostatic Arterial Embolization to Treat Benign Prostatic HyperplasiaJournal of Vascular and Interventional Radiology, 2011
- Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstructionBJU International, 2011
- Prostatic Artery Embolization as a Primary Treatment for Benign Prostatic Hyperplasia: Preliminary Results in Two PatientsCardioVascular and Interventional Radiology, 2009
- Intraprostatic Botulinum Toxin Type A Injection in Patients Unfit for Surgery Presenting with Refractory Urinary Retention and Benign Prostatic Enlargement. Effect on Prostate Volume and Micturition ResumptionEuropean Urology, 2008
- Epithelializing Stent for Benign Prostatic Hyperplasia: A Systematic Review of the LiteratureJournal of Urology, 2007
- Intravesical calculus secondary to ethanol gel injection into the prostateUrology, 2005
- Evaluation of the Transurethral Ethanol Ablation of the Prostate (TEAP) for Symptomatic Benign Prostatic Hyperplasia (BPH): A European Multi-Center EvaluationEuropean Urology, 2004
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994